Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TDTT | -0.03% | $2.38B | 0.18% |
TFLO | -0.15% | $6.75B | 0.15% |
DBC | -0.17% | $1.36B | 0.87% |
CARY | -0.18% | $347.36M | 0.8% |
VGLT | -0.21% | $10.02B | 0.03% |
GOVI | 0.28% | $1.07B | 0.15% |
SHYM | -0.29% | $318.40M | 0.35% |
SCHP | 0.40% | $12.97B | 0.03% |
GOVT | -0.43% | $26.61B | 0.05% |
VTIP | -0.47% | $13.72B | 0.03% |
SCHO | 0.49% | $10.65B | 0.03% |
EDV | -0.49% | $4.00B | 0.05% |
SCHQ | -0.50% | $950.81M | 0.03% |
TLH | 0.52% | $10.21B | 0.15% |
MMIT | 0.53% | $834.61M | 0.3% |
TOTL | -0.53% | $3.51B | 0.55% |
PDBC | -0.54% | $4.89B | 0.59% |
SPTL | -0.55% | $11.79B | 0.03% |
BIL | -0.59% | $41.88B | 0.1356% |
TLT | 0.64% | $51.94B | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FATBB | 0.03% | $56.94M | -23.78% | 14.95% |
AEP | 0.05% | $57.54B | +27.77% | 3.31% |
OCX | 0.06% | $84.37M | +0.34% | 0.00% |
ZCMD | 0.12% | $32.02M | -17.53% | 0.00% |
SIGI | 0.16% | $5.60B | -12.19% | 1.59% |
CAG | -0.17% | $12.59B | -9.22% | 5.19% |
CMTL | -0.24% | $47.84M | -46.73% | 0.00% |
CLX | 0.25% | $18.19B | +0.54% | 3.24% |
NEUE | 0.32% | $57.12M | +4.27% | 0.00% |
AON | -0.32% | $85.54B | +22.05% | 0.68% |
X | 0.33% | $9.60B | +1.24% | 0.50% |
MMC | 0.33% | $119.66B | +19.72% | 1.29% |
CHD | -0.36% | $26.66B | +5.00% | 1.03% |
FTNT | -0.37% | $75.42B | +37.52% | 0.00% |
NOC | 0.41% | $74.14B | +12.07% | 1.60% |
LOAR | 0.42% | $7.19B | +174.46% | 0.00% |
HRL | 0.44% | $16.84B | -11.83% | 3.62% |
DUK | 0.51% | $93.55B | +25.45% | 3.37% |
XPOF | -0.57% | $275.36M | -45.12% | 0.00% |
FUBO | 0.62% | $1.08B | +101.92% | 0.00% |
Yahoo
Arcutis Biotherapeutics (ARQT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Yahoo
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Cynthia Collins to the Company’s Board of Directors. “I am thrilled to welcome Cindy to our Board,” said Stephen Dilly, MBBS, PhD, Chairman and Chief Executive Officer at Codexis. “She has been at the forefront of innovation across multiple therapeutic modalities and brings a weal
Yahoo
Represents first project to enter the ECO Synthesis™ Innovation Lab Core enzymes for ECO Synthesis™ technology have transitioned from research into development and scale-up as the first step in securing the raw materials supply chain REDWOOD CITY, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced its first revenue-generating contract to manufacture siRNA materia
Yahoo
REDWOOD CITY, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to two new employees as approved by the Compensation Committee of Codexis’ Board of Directors. The newly hired employees received equity awards consisting of an aggregate of (i) options to purchase 10,000 shares of Codexis common stock and (ii) 5,000 restricted stock un
Finnhub
Corporate Presentation March 2025 Codexis: We Make Enzymes Make Drugs Foundational CodeEvolver® Directed...
Yahoo
We feel now is a pretty good time to analyse Codexis, Inc.'s ( NASDAQ:CDXS ) business as it appears the company may be...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IWC | 52.35% | $797.08M | 0.6% |
ARKG | 51.72% | $936.86M | 0.75% |
CPRJ | 51.50% | $48.38M | 0.69% |
PRFZ | 49.50% | $2.34B | 0.39% |
GNOM | 49.46% | $47.13M | 0.5% |
KJAN | 49.41% | $317.59M | 0.79% |
VTWO | 49.05% | $10.92B | 0.07% |
IWM | 48.98% | $62.65B | 0.19% |
XBI | 48.72% | $4.76B | 0.35% |
SCHA | 48.61% | $15.94B | 0.04% |
ESML | 48.24% | $1.76B | 0.17% |
KOMP | 48.24% | $1.95B | 0.2% |
IWO | 48.12% | $10.72B | 0.24% |
SLYV | 48.12% | $3.74B | 0.15% |
SMMD | 48.00% | $1.29B | 0.15% |
NUSC | 47.96% | $1.10B | 0.31% |
FYX | 47.89% | $833.42M | 0.6% |
SPSM | 47.82% | $10.99B | 0.03% |
VIOV | 47.74% | $1.22B | 0.1% |
IWN | 47.72% | $10.95B | 0.24% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VHC | -15.72% | $35.77M | +37.68% | 0.00% |
CBOE | -12.61% | $23.50B | +25.53% | 1.05% |
MRK | -10.14% | $218.76B | -33.33% | 3.60% |
PGR | -9.51% | $164.86B | +33.43% | 1.71% |
CME | -9.15% | $94.61B | +23.82% | 3.89% |
TMUS | -8.88% | $302.06B | +62.05% | 1.14% |
HLN | -8.16% | $45.90B | +23.30% | 0.50% |
OMI | -7.86% | $707.59M | -67.04% | 0.00% |
COR | -7.63% | $54.20B | +13.71% | 0.74% |
TCTM | -7.53% | $3.92M | -82.22% | 0.00% |
CI | -7.46% | $89.99B | -8.07% | 1.68% |
MO | -6.93% | $96.57B | +35.61% | 6.83% |
LITB | -6.83% | $41.93M | -46.48% | 0.00% |
GIS | -6.58% | $32.41B | -14.20% | 3.90% |
CB | -6.39% | $120.74B | +18.35% | 1.19% |
MCK | -6.38% | $86.92B | +28.41% | 0.38% |
GAN | -6.38% | $81.06M | +31.11% | 0.00% |
PBA | -6.07% | $23.73B | +14.96% | 4.86% |
WRB | -5.98% | $26.45B | +22.49% | 0.51% |
T | -5.71% | $201.99B | +59.80% | 3.85% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ACA | 49.23% | $3.97B | -2.61% | 0.27% |
MTUS | 47.90% | $579.41M | -38.76% | 0.00% |
PUBM | 46.85% | $457.13M | -59.91% | 0.00% |
EB | 45.45% | $200.61M | -62.14% | 0.00% |
CLAR | 44.57% | $146.93M | -41.97% | 2.86% |
DNLI | 44.38% | $2.00B | -29.07% | 0.00% |
JYNT | 42.92% | $187.71M | -3.06% | 0.00% |
ABCL | 42.75% | $661.53M | -49.32% | 0.00% |
ALG | 42.64% | $2.19B | -17.41% | 0.63% |
CYRX | 42.18% | $307.45M | -66.41% | 0.00% |
LGIH | 42.06% | $1.57B | -37.22% | 0.00% |
CTS | 41.87% | $1.26B | -6.74% | 0.43% |
TWST | 41.69% | $2.28B | +14.61% | 0.00% |
CERT | 41.01% | $1.65B | -39.40% | 0.00% |
BEAM | 40.98% | $1.85B | -37.74% | 0.00% |
AZEK | 40.90% | $7.06B | +0.06% | 0.00% |
KN | 40.87% | $1.34B | -5.22% | 0.00% |
CLFD | 40.81% | $417.73M | -0.37% | 0.00% |
OPEN | 40.66% | $730.75M | -64.81% | 0.00% |
BLNK | 40.61% | $96.96M | -66.14% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -37.98% | $416.76M | 1.43% |
VIXY | -23.81% | $195.31M | 0.85% |
TAIL | -22.77% | $87.65M | 0.59% |
USDU | -18.15% | $206.96M | 0.5% |
UUP | -14.80% | $325.79M | 0.77% |
VRIG | -11.89% | $1.44B | 0.3% |
IBTP | -10.93% | $111.57M | 0.07% |
KMLM | -9.59% | $218.49M | 0.9% |
DBE | -7.10% | $55.52M | 0.77% |
IVOL | -6.29% | $476.36M | 1.02% |
BNO | -6.26% | $99.25M | 1% |
CTA | -6.25% | $978.30M | 0.76% |
USO | -6.09% | $972.70M | 0.6% |
USL | -5.68% | $47.77M | 0.85% |
OILK | -5.54% | $67.85M | 0.69% |
DBO | -4.64% | $202.41M | 0.77% |
KRBN | -4.30% | $175.08M | 0.85% |
UGA | -4.15% | $87.23M | 0.97% |
UNG | -4.09% | $397.59M | 1.06% |
XONE | -4.08% | $631.21M | 0.03% |
Current Value
$2.301 Year Return
Current Value
$2.301 Year Return